Treatment of hepatitis B: Is there still a role for interferon?-Reference-Cited by-同舟云学术

Treatment of hepatitis B: Is there still a role for interferon?

Published:2018-02 Issue: Volume:38 Page:79-83
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Viganò Mauro¹,Grossi Glenda²,Loglio Alessandro²,Lampertico Pietro²^ORCID

Affiliation:

1. Hepatology Division; Ospedale San Giuseppe; Università degli Studi di Milano; Milan Italy

2. CRC “A.M. e A. Migliavacca” Center for the Study of Liver Disease; Division of Gastroenterology and Hepatology; Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico; Università degli Studi di Milano; Milano Italy

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.13635/fullpdf

Reference29 articles.

1. Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B;Lau;N Engl J Med,2005

2. Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial;Janssen;Lancet,2005

3. Peginterferon alfa-2a alone, lamivudine alone, and the two in combination in patients with HBeAg-negative chronic hepatitis B;Marcellin;N Engl J Med,2004

4. Sustained response to peginterferon alfa-2a (40 kD) with or without lamivudine in Asian patients with HBeAg-positive and HBeAg-negative chronic hepatitis B;Piratvisuth;Hepatol Int,2008

5. Sustained HBeAg and HBsAg loss after long term follow-up of HBeAg-positive patients treated with peginterferon alpha-2b;Buster;Gastroenterology,2008

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the role of GTPase in inhibiting HBV replication and enhancing interferon therapy efficacy in chronic hepatitis B patients;Microbial Pathogenesis;2024-09

2. HBcrAg values may predict virological and immunological responses to pegIFN-α in NUC-suppressed HBeAg-negative chronic hepatitis B;Gut;2024-07-20

3. Guanylate-Binding Protein 1 (GBP1) Enhances IFN-α Mediated Antiviral Activity against Hepatitis B Virus Infection;Polish Journal of Microbiology;2024-06-01

4. Factors Positively Correlated with Hepatitis B Surface Antigen Seroconversion in Chronic Hepatitis B;Journal of Personalized Medicine;2024-04-05

5. Elimination of the hepatitis B virus: A goal, a challenge;Medicinal Research Reviews;2024-03-25